An Open-Label, Single-Arm, Pilot Intervention Study to Assess the Efficacy and Safety of Apixaban in Heparin-Induced Thrombocytopenia

This article is protected by copyright. All rights reserved.PMID:35656855 | DOI:10.1002/jcph.2096

Source: The Journal of Clinical Pharmacology - June 3, 2022 Category: Drugs & Pharmacology Authors: Maryam Farasatinasab Saeedeh Baloochzehi Omid Moradi Moghamddam Nafiseh Ansarinejad Mahmonir Mohammadi Somayyeh Nasiripour Source Type: research